These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11363650)

  • 1. Nevirapine recommended for approval.
    BETA; 1996 Jun; ():6-7. PubMed ID: 11363650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA approves first new class of HIV drugs. Food and Drug Administration.
    AIDS Alert; 1996 Aug; 11(8):89. PubMed ID: 11363655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nevirapine surprise.
    Smart T
    GMHC Treat Issues; 1996; 10(6/7):25. PubMed ID: 11363640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nevirapine expanded access.
    Posit Aware; 1996; 7(2):5. PubMed ID: 11363363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-nucleoside reverse transcriptase inhibitors.
    Bowers M
    BETA; 1996 Jun; ():19-22. PubMed ID: 11363645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nevirapine, the first of a new class of NNRTI drugs arrives in pharmacies.
    Crit Path AIDS Proj; 1996; (No 31):18-9. PubMed ID: 11363827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nevirapine: new drug, new class, new questions.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1996 Jul; 2(7):8-13. PubMed ID: 11363750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nevirapine approved by FDA. Food and Drug Administration.
    Bowersox J
    NIAID AIDS Agenda; 1996 Sep; ():10. PubMed ID: 11363918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nevirapine approval expands combo possibilities--and HIV suppression.
    Vazquez E
    Posit Aware; 1996; 7(5):9. PubMed ID: 11363791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nevirapine--first of a new class of drugs.
    PI Perspect; 1996 Sep; (No 19):9-10. PubMed ID: 11363907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nevirapine approved.
    AIDS Patient Care STDS; 1996 Dec; 10(6):378. PubMed ID: 11361568
    [No Abstract]   [Full Text] [Related]  

  • 12. Highlights from the FDA antiviral drug advisory committee meetings, February 27-March 1, 1996.
    Baker R
    BETA; 1996 Mar; ():7-13. PubMed ID: 11363321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA approval of nevirapine for HIV.
    Am Fam Physician; 1996 Oct; 54(5):1805-6. PubMed ID: 8857799
    [No Abstract]   [Full Text] [Related]  

  • 14. Viramune (Nevirapine) is approved for children.
    Vazquez E
    Posit Aware; 1998; 9(6):17. PubMed ID: 11366470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA news. Food and Drug Administration.
    Res Initiat Treat Action; 1999 Jan; 5(1):20. PubMed ID: 11366229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA looks at full approval for d4T. Food and Drug Administration.
    Posit Aware; 1996; 7(1):7. PubMed ID: 11363131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nevirapine receives green light from Health Protection Branch.
    TreatmentUpdate; 1998 Oct; 10(8):4-5. PubMed ID: 11365878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA notifications. Reyataz is approved for HIV treatment.
    AIDS Alert; 2003 Sep; 18(9):119-20. PubMed ID: 14686309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA approves 3TC and saquinavir. Food and Drug Administration.
    Baker R
    BETA; 1995 Dec; ():5, 9. PubMed ID: 11363011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three days that shook the world.
    Gilden D; Smart T
    GMHC Treat Issues; 1996 Mar; 10(3):1-5. PubMed ID: 11363388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.